Danaher to Buy IRIS International for $355M

Reuters

Industrial and medical conglomerate Danaher Corp said it will buy diagnostics company IRIS International Inc for $355 million.

Danaher will pay $19.50 in cash for each IRIS share, representing a premium of about 45 percent to the stock's Friday's close.

Continue Reading Below

The deal is expected to close during the fourth quarter of this year, Danaher said.

Danaher shares closed $54.76 on Friday on the New York Stock Exchange.